2025-10-28

Q3 2025 Results

2025-08-11

Q2 2025 Results

2025-05-07

Q1 2025 Results

2024-11-04

Q3 2024 Results

Revenue data not extractable from XBRL metadata provided

2024-08-09

Q2 2024 Results

2025-02-27

FY24 2024 Results

2025-11-21

Appointed Scott Gottlieb as Director

Former FDA Commissioner (2017-2019) joins board

2025-11-13

Bylaws Amendment

Changed Delaware registered office and agent

2025-11-07

UBS Healthcare Conference Presentation

Management presentation Nov 10, 2025 at 8:45 AM ET

2025-10-28

Q3 2025 Earnings

Third quarter 2025 results announced

2025-09-08

Investor Meetings & 2025 EPS Guidance Reaffirmed

Reaffirmed 2025 adjusted EPS outlook, Amedisys acquisition closed Aug 2025

2025-08-20

Board Governance Restructuring

New Public Responsibility Committee created, McNabb appointed Lead Independent Director

2025-07-31

CFO Change

Wayne DeVeydt appointed CFO effective Sept 2, replacing John Rex

2025-07-29

Q2 2025 Earnings

Second quarter 2025 results announced

2025-07-24

DOJ Investigation

Criminal and civil DOJ investigation into Medicare program participation

2025-06-20

Debt Offering

$3B notes issued across 4 tranches, rates 4.4%-5.95%

2025-06-04

Annual Shareholder Meeting & CEO Equity Cancellation

Former CEO Andrew Witty's performance RSUs cancelled upon retirement

2025-05-21

Director Andrew Witty Resigned

Andrew Witty resignation effective May 20, 2025

2025-05-14

CEO Change - Witty Out, Hemsley In

Andrew Witty stepped down, Steve Hemsley appointed CEO with $60M equity award

2025-04-29

Executive Reshuffling

Heather Cianfrocco moves to EVP Governance/Compliance, Patrick Conway becomes Optum CEO

2025-04-17

Q1 2025 Earnings

First quarter 2025 results announced

2025-01-16

Q4 2024 Earnings

Q4 and full year 2024 results announced

2024-12-04

CEO Death

Brian Thompson, CEO of UnitedHealthcare, passed away

2024-12-03

2025 Financial Outlook

2024 outlook update and initial 2025 projections announced

2024-11-26

Investor Conference Announcement

Annual investor conference Dec 4, 2024 at 8:00 AM EST in NYC

2024-10-15

Q3 2024 Earnings

Third quarter 2024 results announced

2024-07-25

Debt Offering

$12B multi-tranche notes, rates 4.75%-5.75%

2024-07-16

Q2 2024 Earnings

Second quarter 2024 results announced

2024-06-07

Annual Shareholder Meeting

All 10 directors elected, executive compensation approved